Business Context and Reporting Period
This Form 8-K is a current report filed by Onconova Therapeutics, Inc. (not Traws Pharma, Inc., as indicated in the metadata) on May 14, 2021, regarding an event that occurred on May 11, 2020. The company is incorporated in Delaware and its common stock (ONTX) and warrants (ONTXW) are listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status regarding stock listing requirements.
Material Changes
The primary material change reported is the receipt of a notice from The Nasdaq Capital Market indicating the Company failed to comply with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). Specifically, the Company's common stock has not maintained a minimum closing bid price of at least $1.00 per share.
Guidance, Outlook, and Risks
- Compliance Period: The Company has a 180-calendar-day grace period, extending until November 8, 2021, to regain compliance.
- Compliance Criteria: To regain compliance, the common stock must maintain a minimum closing bid price of at least $1.00 per share for a minimum of ten consecutive business days during the grace period.
- Secondary Compliance Option: If the Company fails to comply by November 8, 2021, it may be afforded a second 180-day period. Qualifying for this extension requires meeting the market value of publicly held shares and all other initial listing standards, except the minimum bid price. The Company may need to effect a reverse stock split to cure the deficiency.
- Risks: If the Company does not regain compliance within the allotted periods, its common stock will be subject to delisting. The Company may appeal such a determination to a Nasdaq Hearings Panel.
- Management Commentary: Management intends to monitor the closing bid price and consider available options to resolve the noncompliance. However, there is no assurance that the Company will be able to regain and sustain compliance.
Investor Verification Checklist
- Verify the current closing bid price of ONTX to assess proximity to the $1.00 threshold.
- Monitor the Company's stock price for ten consecutive business days to determine if the initial grace period compliance criteria are met.
- Review future filings for announcements regarding a potential reverse stock split if the initial grace period expires without compliance.
- Check for any subsequent Nasdaq notices regarding the status of the delisting risk or approval of a second compliance period.